Literature DB >> 10680648

Free radicals are involved in cancer procoagulant-induced platelet activation.

B Olas1, B Wachowicz, W P Mielicki, A Buczyński.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10680648     DOI： 10.1016/s0049-3848(99)00129-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

1.  Venous thromboembolism in cancer patients referred to the American University of Beirut-Medical Center secondary to deep vein thrombosis; occurrence and risk factors.

Authors:  Wissam H Sleiman Zade Asfahani; Ali T Taher; Denize Al Rahawi; Ismail Khalil
Journal:  J Thromb Thrombolysis       Date:  2005-12       Impact factor: 2.300

Review 2.  Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.

Authors:  Paul Jurasz; David Alonso-Escolano; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2004-10-18       Impact factor: 8.739

Review 3.  Interaction between circulating cancer cells and platelets: clinical implication.

Authors:  Xiao-Liang Lou; Jian Sun; Shu-Qi Gong; Xue-Feng Yu; Rui Gong; Huan Deng
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

4.  The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation.

Authors:  Nalise Low Ah Kee; Jason Krause; Gregory L Blatch; Koji Muramoto; Kazuo Sakka; Makiko Sakka; Ryno J Naudé; Leona Wagner; Raik Wolf; Jens-Ulrich Rahfeld; Hans-Ulrich Demuth; Wojciech P Mielicki; Carminita L Frost
Journal:  Protein J       Date:  2015-10       Impact factor: 2.371
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.